Dr. Seunghwan Lim joins Celloram as VP and Director of Scientific Operations of our Cell Therapy Program. Dr. Lim completed his Ph.D. in cancer biology and therapeutics development at SUNY Upstate Medical University and his postdoctoral training at the National Cancer Institute, NIH and Case Western Reserve University.
His research interests largely focus on cellular signaling events, specifically the TGF-β signaling pathway. TGF-β is a multifunctional cytokine that plays an important role in regulating malignant cancer behaviors.
“With over 20 years of research experiences, I feel like I have to use this knowledge to develop something more special that can save some lives” says Dr. Lim.
We are thrilled to welcome Dr. Lim to Team Celloram.